EMILY HARKEY: Open Payments
NPI 1841831708 · COLUMBIA, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,018 in 109 payments from 12 companies in 2025. Trend: 2023 $1,204 · 2024 $1,523 · 2025 $2,018
Food & beverage: $2,018
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 42 | $763 |
| Takeda Pharmaceuticals U.S.A., Inc. | 19 | $383 |
| PFIZER INC. | 18 | $285 |
| Janssen Biotech, Inc. | 11 | $229 |
| Celltrion USA Inc. | 4 | $76 |
| QOL Medical, LLC | 4 | $73 |
| Sandoz Inc. | 4 | $66 |
| Lilly USA, LLC | 3 | $60 |
| Organon LLC | 1 | $29 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $21 |
Products named: RINVOQ, ENTYVIO, TREMFYA, XELJANZ, VELSIPITY, VEGZELMA, Sucraid, SKYRIZI.
Industry payments across SC — which companies pay providers there.
